Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: The Leipzig experience

Hormone Research

Volumn 70, Issue 1, 2008, Pages 42-50

  Hoepffner, Wolfgang ^a,b   Kaufhold, Antje ^a   Willgerodt, Helmut ^a   Keller, Eberhard ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b NONE   (Germany)

Author keywords

Congenital adrenal hyperplasia; Final height; Height corrected by target height; Therapy monitoring

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; FLUDROCORTISONE; HYDROCORTISONE; PREDNISOLONE; STEROID 21 MONOOXYGENASE;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BONE AGE; BONE MATURATION; CHILD; CHILD GROWTH; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; GENE MUTATION; GENETIC DISORDER; GROWTH RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROID THERAPY;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; ANTI-INFLAMMATORY AGENTS; BODY HEIGHT; DESOXYCORTICOSTERONE; FEMALE; FLUDROCORTISONE; FOLLOW-UP STUDIES; GERMANY; GROWTH DISORDERS; HOSPITALS, UNIVERSITY; HUMANS; HYDROCORTISONE; MALE; MINERALOCORTICOIDS; PREDNISOLONE; RETROSPECTIVE STUDIES; STEROID 21-HYDROXYLASE;

EID: 46349111204     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000129677     Document Type: Article

References (42)

1. Eugster EA, DiMeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH: Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr 2001;138:26-32.
2. Hargitai G, Solyom J, Battelino T, Lebl J, Pribilincova Z, Hauspie R, Kovacs J, Waldhauser F, Frisch H and the MEWPE-CAH study group: growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Horm Res 2001;55:161-171.
3. Manoli I, Kanaka-Gantenbein C, Voutetakis A, Manitia-Christidi M, Dacou-Voutetakis C: Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome. Clin Endocrinol 2002;57:669-676.
4. Muirhead S, Sellers EAC, Guyda H, in collaboration with the Canadian Pediatric Endocrine Group: Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia. J Pediatr 2002;141:247-252.
5. Van der Kamp HJ, Otten BJ, Buitenweg N, DeMuinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM: Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients. Arch Dis Childh 2002;78:139-144.
6. Pinto G, Tardy V, Trivin C, Thalassinos C, Lortat-Jacob S, Nihoul-Fekete C, Morel Y, Brauner R: Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management. J Clin Endocrinol Metab 2003;88:2624-2633.
7. Balsamo A, Cicognani A, Baldazzi L, Barbaro M, Baronio F, Gennari M, Bal M, Cassio A, Kontaxaki K, Cacciari E: CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency. J Clin Endocrinol Metab 2003;88:5680-5688.
8. Brunelli VL, Russo G, Bertelloni S, Gargantini L, Balducci R, Chiesa L, De Sanctis C, Einaudi S, Virdis R, Saggese G, Chiumello G: Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the Italian experience. J Pediatr Endocrinol Metab 2003;16(suppl):277-283.
9. Punthakee Z, Legault L, Polychronakos C: Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. J Pediatr 2003;143:402-405.
10. Rivkees SA, Crawford JD: Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 2000;106:767-773.
11. Lin-Su K, Vogiatzi MG, Marshall I, Harbinson MD, Macapagal MC, Betensky B, Tansil S, New MI: Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2005;90:3318-3325.
12. Soliman AT, AlLamki M, AlSami I, Asfour M: Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism 1997;46:513-517.
13. Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB: Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2000;85:1114-1120.
14. Greulich WW, Pyle SI: Radiographic atlas of skeletal development of the hand and the wrist, ed 2. Stanford, Stanford University Press, 1959.
15. Hoepffner W, Herrmann A, Willgerodt H, Keller E: Blood pressure in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 2006;19:705-711.
16. Hubl W, Feher T, Rohde W, Doerner G, Taubert H, Freymann E: Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia. Endokrinologie 1982;79:165-172.
17. Hoepffner W, Hubl W: Studies on the diurnal variations of 17-hydroxyprogesterone in saliva by enzyme immunoassay in patients with congenital adrenal hyperplasia. Exp Clin Endocrinol 1986;87:189-194.
18. Tanner JM, Goldstein H, Whitehouse RH: Standards for children's height at ages 2-9 years allowing for height of parents. Arch Dis Child 1979;47:755-762.
19. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al: Percentiles of body mass index in children and adolescents evaluated from different regional German studies (in German). Monatsschr Kinderheilk 2001;149:807-818.
20. Prader A: The genitalia in female pseudohermaphroditism due to adrenogenital syndrome (in German). Helv Paediatr Acta 1954;9:231-248.
21. Wedell A, Thilen A, Martin-Ritzen E, Stengler B, Luthman H: Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 1994;78:1145-1152.
22. Hoepffner W, Schulze E, Bennek J, Keller E, Willgerodt H: Pregnancies in patients with congenital adrenal hyperplasia with complete or almost complete impairment of 21-hydroxylase activity. Fertil Steril 2004;81:1314-1321.
23. Prader A, Largo RH, Molinari L, Issler C: Physical growth of Swiss children from birth to 20 years of age: first Zurich longitudinal study of growth and development. Helv Paediatr Acta 1989;52(suppl):1-125.
24. Tanner JM, Whitehouse RH, Takaish M: Standards from birth to maturity for height, weight, height velocity and weight velocity: British children. Arch Dis Child 1966;41:613-635.
25. Jaaskelainen J, Voutilainen R: Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr Res 1997;41:30-33.
26. Stikkelbroeck NMML, van't Hof-Grootenboer BAE, Hermus ARMM, Otten BJ, van't Hof MA: Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: In early infancy and (pre)-puberty. J Clin Endocrinol Metab 2003;88:3525-3530.
27. Brachet CF, Tenoutasse S, Heinrichs C, Massa G: Early growth in 21 infants with salt wasting congenital adrenal hyperplasia. Horm Res 2003;60(suppl 2):79.
28. Bongiovanni AM, Moshang T, Parks JS: Maturational deceleration after treatment of congenital adrenal hyperplasia. Helv Paediatr Acta 1973;28:127-134.
29. Kruse B, Riepe FG, Krone N, Bosinski HAG, Kloehn S, Partsch CJ, Sippell WG, Mönig H: Congenital adrenal hyperplasia: how to improve the transition from adolescence to adult life. Exp Clin Endocrinol Diabetes 2004;112:343-355.
30. Charmandari E, Brook CGD, Hindmarsh PC: Classic congenital adrenal hyperplasia and puberty. Eur J Endocrinol 2004;151:U77-U82.
31. Riepe FG, Krone N, Viemann M, Partsch CJ, Sippell WG: Management of congenital adrenal hyperplasia: results of the ESPE Questionnaire. Horm Res 2002;58:196-205.
32. Charmandari E, Johnston A, Brook CGD, Hindmarsh PC: Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol 2001;169:65-70.
33. Gröschl M, Rauh M, Doerr HG:Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2002;87:1200-1204.
34. Bode HH, Rivkees SA, Cowley DM, Pardy K, Johnson S: Home monitoring of 17-hydroxyprogesterone levels in congenital adrenal hyperplasia with filter paper blood samples. J Pediatr 1999;134:185-189.
35. Young MC, Hughes IA: Response to treatment of congenital adrenal hyperplasia in infancy. Arch Dis Child 1990;65:441-444.
36. Sandrini R, Jospe N, Migeon CJ: Temporal and individual variations in the dose of glucocorticoid used for the treatment of saltlosing congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency. Acta Paediatr Suppl 1993;388:56-60.
37. Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A: Growth pattern during the first 36 month of life in congenital adrenal hyperplasia (21-hydroxylase deficiency). Horm Res 1997;47:17-22.
38. Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CGD, Hindmarsh PC: Oral hydrocortisone in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion. J Clin Endocrinol Metab 2002;87:2238-2244.
39. Lopes LA, Dubius JM, Vallotton MB, Sizonenko PC: Should we monitor more closely the dosage of 9-alpha-fluorohydrocortisone in salt-losing congenital adrenal hyperplasia? J Pediatr Endocrinol Metab 1998;11:733-737.
40. Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW; ESPE/LWPES CAH Working Group: Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and The Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002;58:188-195.
41. Cornean RE, Hindmarsh PC, Brook CGD: Obesity in 21-hydroxylase deficient patients. Arch Dis Child 1998;78:261-263.
42. Völkl TM, Simm D, Beier C, Doerr HG: Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 2006;117:e98-e105.